Skip to main content
Safran logo

Safran — Investor Relations & Filings

Ticker · SAF ISIN · FR0000073272 LEI · 969500UIC89GT3UL7L24 PA Manufacturing
Open in API
Filings indexed 1,237 across all filing types
Latest filing 2013-03-12 Share Issue/Capital Cha…
Country FR France
Listing PA SAF

About Safran

https://www.safran-group.com/

Safran is a high-technology group operating in the aviation, defense, and space markets. The company's core activities include the design, development, and production of aircraft and helicopter engines, nacelles, and propulsion systems for both civil and military applications. Safran is also a leading supplier of aircraft equipment, manufacturing key systems such as landing gear, wheels and brakes, avionics, and navigation systems. Its portfolio extends to aircraft interiors, including passenger seats and integrated cabins. For the defense sector, the company provides a wide range of systems and equipment for air, land, and naval forces. In the space domain, Safran specializes in rocket propulsion systems and high-performance space optics.

Recent filings

Filing Released Lang Actions
Safran : Statement about the number of shares composing the share capital and the number of voting rights
Share Issue/Capital Change Classification · 95% confidence The document is titled 'MONTHLY STATEMENT ABOUT THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND THE NUMBER OF VOTING RIGHTS' and references French regulatory articles (AMF). It provides a specific table detailing the total number of shares and voting rights as of a recent date (February 28, 2012, relative to the filing date of March 12, 2013). This content directly relates to the structure of the company's capital and voting power, which is a specific type of regulatory disclosure. It is not an AGM presentation, a full annual/interim report, an earnings release, or a director's dealing. It most closely aligns with disclosures related to capital structure changes or specific regulatory reporting that doesn't fit the other primary categories. Given the focus on the total number of shares and voting rights, it is a specific regulatory filing. Since there is no explicit category for 'Share Capital/Voting Rights Statement', and it is a formal regulatory disclosure, the most appropriate general category is 'Regulatory Filings' (RNS), as it is a mandatory, periodic disclosure that doesn't fit the more specific financial or corporate action codes.
2013-03-12 English
Performances 2012 record pour Safran
Earnings Release Classification · 98% confidence The document is a detailed press release dated February 21, 2013, summarizing the financial performance of Safran for the fiscal year 2012. It contains key financial metrics (revenue, operating income, net income, cash flow), commentary from the CEO, and forward-looking statements for 2013. The content is comprehensive, covering the full annual results, which strongly suggests it is an Earnings Release (ER) or potentially an Interim/Quarterly Report (IR) if it were for a shorter period. Since it explicitly covers the 'Exercice 2012' (Fiscal Year 2012) and provides full-year figures, it functions as the primary announcement of annual results. While a 10-K is the official regulatory filing, this document format—a press release detailing key figures and management commentary—is characteristic of an Earnings Release (ER). It is not a transcript (CT), a proxy statement (PSI), or a formal Audit Report (AR). Given the depth of the financial summary, ER is the most appropriate classification for this type of announcement document. FY 2012
2013-02-21 French
Safran: record 2012 results
Earnings Release Classification · 97% confidence The document is titled "Safran: record 2012 results" and contains detailed financial figures for the full year 2012, including revenue, operating income, net income, balance sheet data, cash flow, and a forward-looking outlook for 2013. It explicitly mentions that the Board of Directors approved the financial statements for the full year 2012 on February 20, 2013. This content structure—comprehensive annual financial performance review, key figures, commentary, and outlook—is characteristic of an Annual Report or a closely related document. However, the text is presented as a press release announcing the results, which often precedes or summarizes the official 10-K filing. Given the depth of the financial data provided (including detailed reconciliation tables and balance sheet items), it is more substantial than a typical Earnings Release (ER). Since it covers the *full year* results and is highly detailed, it strongly aligns with the content of an Annual Report (10-K), even if presented in a press release format. If a formal 10-K were available, this would be the press release accompanying it. In the absence of explicit SEC filing headers (like '10-K'), the comprehensive nature of the full-year financial disclosure points towards the Annual Report category (10-K) as the best fit for the *content type*, rather than just an ER or RPA. FY 2012
2013-02-21 English
Safran : déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote - janvier 2013
Share Issue/Capital Change Classification · 95% confidence The document is titled "PUBLICATION MENSUELLE DU NOMBRE D'ACTIONS COMPOSANT LE CAPITAL SOCIAL ET DU NOMBRE TOTAL DE DROITS DE VOTE" (Monthly publication of the number of shares comprising the share capital and the total number of voting rights). It explicitly references the French Commercial Code (Code de commerce) and the AMF General Regulation (Règlement général de l'Autorité des Marchés Financiers). The content provides a table detailing the number of shares and voting rights as of January 31, 2013. This specific disclosure relates to the total share capital and voting rights, which is a mandatory periodic regulatory filing in France, often associated with capital structure updates or general regulatory reporting. Given the options, this is a specific regulatory disclosure about the capital structure, which aligns best with 'Share Issue/Capital Change' (SHA) or a general 'Regulatory Filing' (RNS). Since it is a mandatory monthly disclosure about the total number of shares and voting rights, it is a direct update on the capital structure, making SHA the most precise fit, although RNS is a possibility if SHA is reserved strictly for new issues/splits. However, reporting the total share count is fundamental to capital structure reporting. Given the nature of the data (total shares and voting rights), SHA is the most appropriate classification over the general RNS.
2013-02-11 French
Safran : statement about the number of shares composing the share capital and the number of voting rights
Share Issue/Capital Change Classification · 95% confidence The document is titled 'MONTHLY STATEMENT ABOUT THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND THE NUMBER OF VOTING RIGHTS' and references French regulatory articles (AMF). It provides a specific snapshot of the total number of shares and voting rights as of a specific date (January 31, 2012). This content directly relates to the structure of the company's capital and voting power, which aligns best with announcements concerning capital structure or general regulatory disclosures. Since there is no specific code for 'Share Capital/Voting Rights Statement', I must evaluate the closest fit. It is not a dividend (DIV), a general share issue (SHA), or a director's dealing (DIRS). It is a periodic statement about the capital base. Given the options, this type of periodic disclosure about the capital structure and voting rights is most closely related to general regulatory reporting or capital structure updates. However, none of the codes perfectly match a 'Monthly Share Capital Statement'. It is a regulatory filing, but the content is very specific. Since it details the number of shares and voting rights, it is a fundamental piece of corporate structure information. It is not a major shareholding notification (MRQ) as it reports the company's total, not an investor's stake. Given the options, 'RNS' (Regulatory Filings - fallback) is a possibility, but 'SHA' (Share Issue/Capital Change) is often used for changes, and this is a statement of the current state. Since it is a mandatory monthly statement detailing the capital base, it fits best under a general regulatory disclosure category. I will classify it as RNS as it is a specific, recurring regulatory disclosure that doesn't fit the other specific capital/share codes (like DIV, SHA, POS).
2013-02-11 English
ANNULE ET REMPLACE. Bilan semestriel Safran (31 décembre 2012) du contrat de liquidité
Regulatory Filings Classification · 85% confidence The document is titled "BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE" (Semi-annual balance sheet of the liquidity contract) and reports the status of a liquidity contract with Oddo Corporate Finance as of December 31, 2012. This document details the holdings (shares and cash) related to a liquidity agreement, which is a specific financial arrangement often related to market making or share stabilization. This type of filing, detailing the status of a specific financial contract or instrument balance, does not perfectly align with the major categories like 10-K, ER, or IR. It is a specific financial disclosure related to market operations. Given the options, it is a specialized financial report. Since it is a balance sheet/status report for a specific contract, and not a general earnings release (ER) or comprehensive interim report (IR), it fits best under a specific financial disclosure category. However, none of the codes perfectly match 'Liquidity Contract Balance Sheet'. Given the context of financial reporting, and that it is a specific, periodic financial disclosure, it is closest to a specialized financial update. Since it is a report detailing specific financial metrics (shares/cash balance) related to a contract, and not a general announcement, I will evaluate the closest fit. It is not a dividend (DIV), NAV, or standard interim report (IR). It is a report on a financial arrangement. In the absence of a specific 'Liquidity Contract Report' code, and considering it is a formal, periodic financial statement for a specific purpose, it is most likely classified as a specialized financial filing. Given the available codes, 'IR' (Interim/Quarterly Report) is too broad if this is not the main financial report, and 'AR' (Audit Report) is incorrect. 'XLSX' is incorrect as it's text. 'RNS' is the fallback. However, since it is a formal, periodic financial statement (Bilan Semestriel), it is a type of financial report. If we must choose from the list, and recognizing it is a formal, periodic financial disclosure, it is often grouped with other periodic financial statements. Since it is a 'Bilan Semestriel' (Semi-annual Balance Sheet), it strongly suggests a periodic financial report, making 'IR' (Interim/Quarterly Report) the most plausible category for a non-annual, comprehensive financial statement, even if specialized. Given the short length and specific nature, it could also be considered a specialized regulatory filing (RNS). I will lean towards the most specific financial report type available that covers non-annual periods, which is IR, but acknowledge its specialized nature. Re-evaluating: This is a report on a liquidity contract, not the company's overall financial performance. It is a highly specific disclosure. If it were a general regulatory filing not covered elsewhere, RNS would apply. Given the options, and its nature as a formal, periodic financial status update, I will classify it as a specialized financial report, leaning towards RNS as the best fit for a non-standard, specific disclosure not covered by ER, IR, or 10-K.
2013-01-14 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.